List of bibliographic references
Number of relevant bibliographic references: 10.
Ident. | Authors (with country if any) | Title |
---|
000146 (2015) |
S. L. Stramer [États-Unis] ; R. Y. Dodd [États-Unis] ; C. Y. Chiu [États-Unis] | Advances in testing technology to ensure transfusion safety – NAT and beyond |
000200 (2014) |
S. L. Stramer [États-Unis] | Current perspectives in transfusion‐transmitted infectious diseases: emerging and re‐emerging infections |
000232 (2013) |
Susan L. Stramer ; Roger Y. Dodd | Transfusion‐transmitted emerging infectious diseases: 30 years of challenges and progress |
000437 (2011) |
J. L. Callum [Canada] ; Y. Lin [Canada] ; A. Lima [Canada] ; L. Merkley [Canada] | Transitioning from ‘blood’ safety to ‘transfusion’ safety: addressing the single biggest risk of transfusion |
000930 (2007) |
| Abstracts for the Joint Conference of the Canadian Society for Transfusion Medicine, Canadian Blood Services and Héma‐Québec, Calgary, Alberta, Canada, May 4–6, 2007 |
000A76 (2005) |
Jay P. Brooks [États-Unis] | Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products |
000B03 (2005) |
M. A. Siegenthaler [Suisse] ; P. Schneider [Suisse] ; D. Vu [Suisse] ; J. Tissot [Suisse] | Haemovigilance in a general university hospital: need for a more comprehensive classification and a codification of transfusion‐related events |
000B37 (2005) |
| Abstracts of the Joint Conference of the Canadian Society for Transfusion Medicine, Canadian Blood Services and Héma‐Québec, Banff, Alberta, Canada, 21–24 April 2005 |
001690 (1996) |
F. C. Chao ; B. K. Kim ; A. M. Houranieh [États-Unis] ; F. H. Liang ; M. W. Konrad ; S. N. Swisher ; J. L. Tullis | Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets |
001D04 (1993) |
S-J. Hwang [République populaire de Chine] ; S-D. Lee [République populaire de Chine] ; Y-H. W. Lee [République populaire de Chine] ; J-C. Wu [République populaire de Chine] ; C-Y. Chan [République populaire de Chine] ; Y-S. Huang [République populaire de Chine] ; Y-J. Wang [République populaire de Chine] ; K-J. Lo [République populaire de Chine] | A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "transfusion"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i \
-Sk "transfusion" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Istex
|étape= Checkpoint
|type= indexItem
|index= Title.i
|clé= transfusion
}}
| This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021 | |